Joel Ernst, MD, teacher of medication and chief of the department of speculative medication, UCSF School of Medication, San Francisco.
Santosha Vardhana, MD, PhD, assistant teacher of medication and going to doctor, Memorial Sloan Kettering Cancer Center, New York City.
Nicolas Vabret, PhD, assistant teacher of medication, Icahn School of Medication at Mount Sinai, New York City.
Medline Plus: “Immune action.”
. Journal of Speculative Medication: ” The lots of faces of the anti-COVID immune action.”
UCSF: “Ask the Professional: Looking For Resistance Versus COVID-19.”
La Jolla Institute for Immunology: “T Cells Take the Lead in Managing SARS-COV-2 and Lowering Covid-19 Intensity.”
. Cell:” Antigen-Specific Adaptive Resistance to SARS-CoV-2 in Severe COVID-19 and Associations with Age and Illness Intensity.”
. Resistance:” Immunology of COVID-19: Existing State of the Science.”
.(* )The Lancet Contagious Illness: ” Genomic proof for reinfection with SARS-CoV-2: a case research study,” and “What reinfections mean for COVI-19.” Johns Hopkins Coronavirus Resource Center.
.(* )The Lancet Contagious Illness:
” Longitudinal antibody and T cell reactions in Ebola infection illness survivors and contacts: an observational friend research study.”
” Decrease of Humoral Reactions versus SARS-CoV-2 Spike in Convalescent People.” Science Immunology: “Perseverance and decay of human antibody action to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 clients.” BROTHER News: “COVID-19 reinfection tracker.”